Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps
María Sandra Domínguez-Sosa, María Soledad Cabrera-Ramírez, Miriam del Carmen Marrero-Ramos, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 485-485
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Federico Sireci, Giovanna Stilo, et al.
American Journal of Otolaryngology (2025) Vol. 46, Iss. 1, pp. 104597-104597
Open Access | Times Cited: 2
Efficacy Assessment of Biological Treatments in Severe Asthma
Daniel Laorden, Javier Domínguez‐Ortega, David Romero, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 321-321
Open Access | Times Cited: 2
Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
Marisa Dorling, Juan Carlos Hernaiz‐Leonardo, Athenea Pascual, et al.
The Laryngoscope (2024) Vol. 134, Iss. 7, pp. 3054-3059
Open Access | Times Cited: 14
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
Clinical Evidence of the Use of Mepolizumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: A Prospective Observational Study
Antonio Moffa, Francesco Iafrati, Lucrezia Giorgi, et al.
Healthcare (2025) Vol. 13, Iss. 4, pp. 419-419
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
Cosimo Galletti, Francesco Ciodaro, María Antonietta Barbieri, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104329-104329
Closed Access | Times Cited: 6
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience.
Gianluca Bellocchi, Antonella Loperfido, Francesco Maria Passàli, et al.
PubMed (2023) Vol. 94, Iss. 5, pp. e2023227-e2023227
Closed Access | Times Cited: 11
Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study
Carlo Cavaliere, Antonella Loperfido, Andrea Ciofalo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3575-3575
Open Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months
Giulia Costanzo, Andrea Ledda, Giada Sambugaro, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 3, pp. 101041-101041
Open Access
The effect of biological agent use on symptoms in patients diagnosed with NSAID-Exacerbated Respiratory Disease (NERD)
Hatice Çelik Tuğlu, Kurtuluş Aksu, Onur Telli, et al.
Revue française d'allergologie (2025) Vol. 65, Iss. 4, pp. 104219-104219
Closed Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP
Cuilian Guo, Feifan Liu, De Yun Wang, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 12, pp. 703-713
Closed Access | Times Cited: 9
Endoscopic Extended Sinus Surgery for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps, the Choice of Mucoplasty: A Systematic Review
Daniel Martín-Jiménez, Ramón Moreno‐Luna, A del Cuvillo, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 12, pp. 733-746
Open Access | Times Cited: 7
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey
Valentin Favier, Clémentine Daveau, Florent Carsuzaa, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e083112-e083112
Open Access | Times Cited: 1
A RESPONSE to comorbid patients – the study protocol
Petros Bakakos, Isam Alobid, Jannis Constantinidis, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 4, Iss. 1, pp. 100343-100343
Open Access | Times Cited: 1
Real-world Outcomes on Quality-of-Life Improvement in Patients with Nasal Polyposis Treated with Mepolizumab. RINOSUR Study
Juan M. Solano, Juan Aguilar-Cantador, María Dolores Noguerol-Pérez, et al.
Acta Otorrinolaringologica (English Edition) (2024)
Closed Access | Times Cited: 1
Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients
María Sandra Domínguez-Sosa, María Soledad Cabrera-Ramírez, Miriam del Carmen Marrero-Ramos, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Polypose naso-sinusienne et biothérapie : revue des études de vraie vie
X. Dufour, Florent Carsuzaa
Revue française d'allergologie (2024) Vol. 64, pp. 103800-103800
Closed Access
Efectividad real de la terapia biológica en el tratamiento de pacientes con rinosinusitis crónica con poliposis nasosinusal
Cristina García-García, Ithzel María Villarreal, Adriana Pardo-Maza, et al.
Revista ORL (2024) Vol. 15, Iss. 2, pp. e31902-e31902
Open Access
Chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) – Mepolizumab überzeugt in Real-World-Studien

Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. 07, pp. 551-551
Closed Access
Page 1 - Next Page

Scroll to top